Arrhythmia Research Technology Inc /de/ (HRT): Marco Benedetti , director of Arrhythmia Research Technology Inc /de/ purchased 500 shares on May 17, 2016. The Insider buying transaction was reported by the company on May 17, 2016 to the Securities and Exchange Commission. The shares were purchased at $3.80 per share for a total value of $1,900.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Mar 17, 2016, Salvatore Jr Emma (CEO) purchased 2,500 shares at $3.90 per share price.On Mar 17, 2016, Derek Thomas Welch (CFO) purchased 360 shares at $4.09 per share price.Also, On Sep 25, 2015, Rodd Friedman (10% owner) purchased 48,644 shares at $6.35 per share price.On Sep 25, 2015, Securities & Co. Ref (10% owner) purchased 6,800 shares at $6.25 per share price.
Shares of Arrhythmia Research Technology (HRT) ended Monday, May 16, 2016 session in red amid volatile trading. The shares closed down -0.2899 points or -7.02% at $3.84 with 22,167 shares getting traded. Post opening the session at $4.02, the shares hit an intraday low of $3.52 and an intraday high of $4.21 and the price vacillated in this range throughout the day. The company has a market cap of $11 M and the number of outstanding shares has been calculated to be 28,16,639 shares. The 52-week high of Arrhythmia Research Technology is $6.81 and the 52-week low is $3.52.
Arrhythmia Research Technology Inc. is a contract manufacturing organization (CMO). Through its wholly owned subsidiary Micron Products Inc. the Company produces medical device technologies requiring precision machining and injection molding. The Company also manufactures components devices and equipment for military law enforcement industrial and consumer product applications. It is a manufacturer and distributor of silver-plated and non-silver plated conductive resin sensors for use in the manufacture of disposable electrodes for electrocardiogram (ECG) diagnostic monitoring and related instrumentation. The Company is also a contract manufacturer of orthopedic implant components for full and partial knee replacements including femorals tibial trays and inserts with capabilities. Its plastic injection molding services are suited to consumable medical products and medical device components.